Clinical Trial Update: In Vivo CAR-T for Refractory Graves' Disease [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 clinical trial is evaluating an in vivo CAR-T therapy for refractory Graves' disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Drugs mentioned

• In vivo CAR-T therapy for Graves' disease

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Graves' Disease | EARLY_Phase 1 | Status: RECRUITING